ReviewMolecular cancer2022

Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition.

Roger J Daly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.